| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 2039 | Bioquin | 0.00162803849483079 | 0.31802719 |
| NSC 33092 | Null | 0.00162803849483079 | 0.27390284 |
| NSC 667909 | Null | 0.00162803849483079 | 0.17702519 |
| NSC 685285 | Null | 0.00162803849483079 | 0.11952367 |
| NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.00162803849483079 | 0.25271363 |
| NSC 725098 | Null | 0.00162803849483079 | 0.33039477 |
| NSC 603086 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- | 0.0019098098157241 | 0.25290373 |
| NSC 702047 | 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(2-furanyl)- | 0.0019098098157241 | 0.37940775 |
| NSC 744622 | 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide | 0.00195569482028893 | 0.13099794 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.00220234298765534 | 0.70884744 |